1. Home
  2. ARCC vs ASND Comparison

ARCC vs ASND Comparison

Compare ARCC & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ares Capital Corporation

ARCC

Ares Capital Corporation

N/A

Current Price

$19.04

Market Cap

13.2B

Sector

Finance

ML Signal

N/A

Logo Ascendis Pharma A/S

ASND

Ascendis Pharma A/S

N/A

Current Price

$249.19

Market Cap

15.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ARCC
ASND
Founded
2004
2006
Country
United States
Denmark
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
15.0B
IPO Year
2004
2014

Fundamental Metrics

Financial Performance
Metric
ARCC
ASND
Price
$19.04
$249.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
21
Target Price
$21.00
★ $304.82
AVG Volume (30 Days)
★ 4.4M
638.5K
Earning Date
10-27-2026
11-16-2026
Dividend Yield
★ 9.89%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.81
N/A
Revenue
N/A
N/A
Revenue This Year
$0.76
$89.94
Revenue Next Year
$6.87
$46.86
P/E Ratio
$23.94
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.40
$188.07
52 Week High
$21.14
$282.15

Technical Indicators

Market Signals
Indicator
ARCC
ASND
Relative Strength Index (RSI) 54.43 64.34
Support Level $18.36 $238.09
Resistance Level $19.35 $260.91
Average True Range (ATR) 0.33 5.32
MACD 0.11 2.51
Stochastic Oscillator 71.74 89.33

Price Performance

Historical Comparison
ARCC
ASND

About ARCC Ares Capital Corporation

Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing in first lien senior secured loans (including unitranche loans, which are loans that combine both senior and subordinated debt, generally in a first lien position) and second lien senior secured loans. In addition to senior secured loans, the company also invests in subordinated loans and preferred equity, it also makes common equity investments.

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.

Share on Social Networks: